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The castor seeds of Ricinus connnunis L. have long been known to be 
very toxic, as few as two or three seeds being fatal to mannnals. The 
toxicity is a protein, ricin, whose structure is unknown, although the 
amino acid composition of certain preparations has been determined. 
Castor seeds have been grown primarily for their oil, but there is no 
ricin present in castor oil. 
Various attempts have been made to isolate, purify and determine 
the mechanism of action of ricin. These attempts have included methods 
whereby the toxin could be separated from a very powerful allergen, which 
is also a protein found in castor seeds. Ricin exhibits proteolytic 
activity and also the property to agglutinate red blood cells . A serious 
problem in working with ricin is the lack of a suitable assay method. 
This investigation was initiated to determine if there were selective 
toxicities for specific organs of the rat, especially the liver and the 
lymphatic system. Several fractionation procedures were used to separate 
proteins and each fraction was tested for toxicity, pathological damage 
and hemagglutination. Some studies were performed to determine if there 
were any changes in red blood cell volume and if any hemoglobin appeared 
in the serum or urine. The effect of ricin as a possible inhibitor of 
crystalline fumarase was te s ted. If r ic i n d i d inh i bit fumar a se, t h is 




Proteins of the castor plant, Ricinus communis L., have teen studied 
since the 1800's. Dixon (15) was the first to isolate a toxic protein frac-
tion from castor seeds ; Stillmark ( 60 ) named the tox in ricin . . Another pro-
tein found in castor seeds is an allergenic factor, which is distinct from 
ricin ( 58 ). These two proteins have received the most interest because 
of their biological activity. Both ricin and the allergen preparations 
consist of more than a single component(14, 16, 18, 21, 27, 32, 33 , 46, 49, 70). 
Ricin is apparently toxic to all species of mammals , although the 
tox icity varies with the species. Guinea pigs appear to be the most sus-
ceptible. Ricin is toxic when ingested orally, injected subcutaneously 
or intravenously, with the latter exhibiting the greatest effect ( 52 ). A 
"latent period" of at least 15 hours intervenes before toxic symptoms 
appear even when quantities greater than a f atal dose have been adminis-
tered (52 ). A dose of 0.5 µg of ricin per kg of body weight injected sub-
cutaneously into a rabbit was fatal in seven days ( 28 , 53, 54). A report ed 
value for a dos e to man was 0 .18 g per kg of body weight , which corre sponds 
to about s i x s eeds; howeve r, l es s concent rations hav e been f atal ( 9 ). 
Ricin is not as tox ic as bacterial exotox ins , bu t more potent than alkaloids 
or inorganic poisons ( 10 ). 
The most wide ly us ed method f or t he iso l ation of r icin has been 
extraction o f oil- f ree seeds with a 10 percent NaCl solution, f ollowed 
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by (NH4)2S04, Na2S04 or MgS04 s~1ting out (14, 21 , 24, 25, 27, 31 , 47 , 
53, 55), Other procedures such as extraction with water, followed by 
acidification with acetic acid and neutralization with NaOH (40) have 
been used. Kunitz and McDonald (31) obtained ricin crystals either in 
the form of rosettes of fine needles or as large prismoidal crystals . 
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The crystalline fornt e>f.'.-r:ioindepended upon the method of crystallization. 
Crystalline ricin was reported to be homogeneous in the ultracentrifuge 
and electrophoresis, but solubility data indicated at least two components 
(27, 31 ). Other evidence has also been found indicating that ricin is 
more than one component ( 12, 14, 16, 18, 19, 27, 28, 31, 7 o) . 
An elemental analysis of ricin shows that it contains no phosphorus 
(26). High contents of arginine have been found (28 , 29 47 ). It was 
found that as the purity of ricin was increased, the amount of sulfur 
decreased (24). The measurement of the sulfur content or the decrease 
in optical or specific rotation upon purification has been proposed as 
a criterion of purity (24). However, various specific rotation values 
have been reported and they appear to be dependent upon the method of 
preparation (24, 27 , 28). 
Ricin shows ultraviolet absorption similar to other proteins with 
maxima at 276 mµ (46) and 279 mµ (31). Various isoelectric points have 
been found between pH 5.2 - 5.8, although pH 6. 0 (46 ) and pH 6. 6 (10 ) 
have been reported. The toxin is stable between pH 3. 8 - 10 , and below 
60° (22, 35) and least soluble between pH 5 - 8. The reported molecular 
weight of the protein has also varied. Kabat (27) reported values between 
77,000 to 85,000; Kunitz (31), 36 ,000; and Corwin ( 10 ) , 50, 000. The 
denaturation of ricin by temperature and pH follows first order kinetics 
(35). Although the structure for ricin is unknown , amino acid composition 
of certain preparations hasl:eendetermired' (28; 29 ., 46; 7:C!J}, In an investi-
gation by Holasek (24), methionine and isoleucine were reported to be 
N-terminal amino acids; however, the preparation was not pure enough to 
make this finding definite. 
In addition to toxicity, ricin exhibits a proteolytic activity which 
is not inactivated by cell cathepsins (45) . Ricin may lose its toxicity 
upon long stanqing (2 1/2 years) (16), with new components appearing in 
the solution (24). Tiiis autolytic or self-digestive action may be due 
to the proteolytic activity (24). On the contrary, purified dry ricin 
preparations suffer no deterioration in their physiological activities 
after being kept for many months (52). ' DeBreton and Moule (34) have 
suggested that the toxicity of ricin may be due to proteolytic activity; 
while Funatsu (19, 20) has reported that proteinase activity was not 
crucial for the toxic action of ricin. Ricin preparations exhibit 
proteolytic activity on other proteins such as pepsin, serum albumin, 
ribonuclease, and casein, with maximum activity being pH dependent (46). 
Digestion of ricin by other protolytic enzymes is difficult, but 
when given enough time the toxicity diminishes with the extent of diges-
tion (18, 28, 34, 62, 69). Tiie toxicity of ricin can also be reduced•: 
with Ca(OH) 2 (59); heavy metals such as zinc, silver (28) and copper (67); 
ethyl alcohol (22); supersonic waves, 555 kilocycles (63); ultraviolet 
light (6); and oxidizing agents as dilute KMn04 (7) , dilute H2 02 (15) 
and dilute iodine solution (7). Ricin toxicity lost by treatment with 
iodine can be partially restored by treating with Na2 S2 03 (4, 7). Ricin 
fermented with yeast also loses a considerable amount of toxicity (8). 
Acetylat ion and: benzolat ion of the free amino groups causes a decrease in 
toxicity. Also, guanidylation at the e-NH2 group of lysine gives a 
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marked decline in toxicity ( 50 ). When heated to boiling in aqueous 
solution toxicity is destroyed (6, 51 ) . 
Another property exhibited by ricin is the agglutination of red 
blood cells. An extensive review has been given by OasGupta ( 11 ) on its 
agglutination property. The ratio of toxicity to hemagglutinating 
activity was not constant with several varieties of castor seeds , suggest -
ing that the two properties might not be attributed to a single protein 
(11). Takahashi et al. (64 , 65 ) isolated a protein hemagglutinin from 
Ricinus sanguineus seed which was distinct from the toxic protein. 
Some of the pa i::holo g :i:cal effects of ricin that have been observed 
are as follows: congestion , hemorrhagic lesions and cellular degenera -
tion of the hypothalmus, adrenals, anterior hypophysis , ovaries and testis; 
degeneration of peripheral nerve ganglia; a variable amount of vasodila-
tion in the parathyroids and pancreatic insular tissue; degeneration of 
lymphatic ganglia in the thymus ; and a hyperfunctional aspect , without 
lesions, in the thyroid (41, 42 ) ; diarrhea and extreme prostration (30 , 38 ) ; 
hemorrhagic conditions of the intestines , renal congestion , hyperemia of 
spinal medulla and brain and severe panophthalmitis (38). ~lso reported 
are inflammation of eyes ( 17 , 38 , 57 ), ed~a of eyes , nose , throat and 
lungs, abdominal pains and vomiting ( 17 , 30 ). In rabbits inJected with 
ricin a secondary hemolysin was observed due to breaking down of red 
blood corpuscles ( 13) " Ricin was also found to inhibit the activity of 
the isolated heart of the rabbit (3) . e Even i n high dilutions ( 10 and 
7 10 ), ricin inhibited the growth of chick embryonic heart , liver and 
stomach in tissue culture. The spleen appeared to be more resisten~ and 
a latent period was observed before the toxic effect appeared (61 ) . 
Strophosomia has been produced by inJecting ricin into hen eggs during 
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development of the embryo (1). By the sixth day the embryo had dis-
integrated, but the heart continued to beat and develop until the ninth 
day (2). DasGupta (12) has reported marked degenerative changes in the 
mesenteric lymph nodes, spleen, mucosa of the small intestine, and liver, 
in rats injected with crude ricin solutions. However, in preparations 
that had been chromatographed, the liver and lymphoid tissues were pre-
ferentially attacked (12). 
A change in blood and bone marrow cells in ricin inJected rabbits 
has been observed. Ricin causes a destruction as well as a stimulatory 
effect on bone ma.rrow. In mature cells, the degenerative effect pre-
dominated, while in younger cells the maturation promoting effect was 
greater (39). Mosinger (43, 44) has shown that ricin produces sarcom-
alytic effects in rats with implanted tumors and blastostimulative 
effects after prolonged administration. He suggested that ricin might 
serve as an anticancer agent. 
As no chemical or biochemical assay has been found suitable, deter-
minations of toxicity have been used as a means of assay. Two methods 
have been used: determination of the LD50 or interpolation on a dose-
survival time curve (10). 
Although ricin has been studied for many years, the mechanism 
of action of ricin is still unknown. Thomson (66) has suggested that 
ricin may interfere with some metabolic process in the liver, possibly 
in the Krebs cycle. Assays of homogenates made from the livers of normal 
and poisoned rats showed no difference in activities except for fumarase 
which decreased in poisoned rats to 66 percent of the normal values. He 
also suggested that doses causing death after several days may involve 
an entirely different mechanism of action than those rats which die 
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rapidly. Mosinger (44) has reported that damage to organs as well as 
necrosis of the sarcoma are due to a direct action of ricin and not 
because of neuro-endocrine related effects. Thus ricin may become of 
importance as an anticancer agent if the mechanism of action can be deter-
mined and controlled. 
CHAPTER III 
EXPERIMENTAL METEODS 
A. Preparation of Defatted Castor Seeds 
Decorticated castor seeds, Ricinus communis _!;., of the Cimarron 
variety (Oklahoma State University, Agronomy Farm, Stillwater; Okla.), 
were pressed ( Carver Press , Model BJ Fred S. Carver, Inc, .i Summit, N.J.) 
at 20,000 lbs/sq in. for 2-3 hours to remove most of the castor oil, The 
pressed seeds were extracted with ether in a Soxhlet extractor for 48 
hours to remove any remaining oil. The defat ted seeds were stored at -13 
to -15° and used as source material for further experiments. 
E. Column Chromatography Preparations 
·1 
,J., o Ambe rlite CG-50 Column 
Ambe rlite CG- 50, Type I, a synthetic weakly acidic cationic exchange 
res in (Rohm and Haas Co.) 100- 200 mest.J wa s cycled by treating a.lt.ernately 
with 0. 1N HCl _, dis tilled water_, O. lN NaOH, and washed t o pH 6. 5 to 7. 0 with 
dis ti.lled wa t er and transferred to a 25 ml burett.e, 1 x 25 cm_, f itted with 
a glaes wool plug and 0. 5 cm of small glass beads. co lumn was t hen 
equilibr a t ed to t he pH of the buffer by continuous e lution with buffer. 
2. DEAE-Cellulose Column 
DEAE-ce llu1.ose ( Sigma Ch~mica l Co. ) wh:i..cb. hec been cycled in the 
same manner as the Amberlite r esin, was ·washed s everal times with 0 . 005 M 
sodium phosphat e buf fe r , pH 6 . 5, and then slurried into a column, 1 x 20 
err, , which was fitted with a coarse sinter ed gla s s dis c. A Nichrome wire 
wi.s used to slurry t he material in the col umn during packing. The column 
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was equilibrated with the phosphate buffer until the effluent was of the 
same pH as the buffer. 
3. Sephadex Column 
Sephadex G-25 (Pharmacia, Uppsala, Sweden) was suspended in O.lN 
NaCl solution and washed repeatedly until the fines were removed and then 
washed several times with 0.05 M sodium phosphate buffer, pH 6.5, before 
being packed into a column 2.5 x 30 cm, fitted with a medium sintered 
glass disc. The material was slurried in as previously described and 
equilibrated to the pH of phosphate buffer. 
C. Protein Determinations 
Protein content of the various fractions was determined by the method 
of Lowry, Rosebrough, Farr and Randall (36). Absorbancy at 280 mµ was 
used to monitor protein ~ontent of fractions separated by column chromatography. 
D. Fractionation Procedure 
In the early phase of this work, the fractionation procedure of 
DasGupta (11) was used, The need for an improved fractionation procedure 
became apparent since the final step in this procedure contained at least 
four components. Thus, a new fractionation. scheme was developed in an 
attempt to further fractionate the components, and was used for the remain-
der of the studies. The procedure is as follows ; 
All operations were performed in a cold room (4-8" ) unless otherwise 
stated. Defatted castor seeds were extracted with 0.85 percent NaCl 
solution (50 ml/g of seeds). A paste was made by grinding seeds wetted 
by a small volume of the NaCl solution in a mortar and pestle. The paste 
was transferred quantitatively to a micro Waring blender, using the 
remaining volume of Na.Cl solution and blended for three minutes at a variac 
(The Superior Electric Co., Bristol, Conn.) setting of 50. The solution 
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was filtered through eight layers of cheese cloth and then centrifuged for 
20 minutes at 10,000 x gin a Lourdes centrifuge, Model LR, at 0-4°. The 
cold supernatant solution was adjusted to pH 5.0 using 2N HCl and O.lN HCl 
for final adjustment. If the solution was at room temperature when the pH 
was adjusted, little or no precipitation occurred. The solution was then 
allowed to sit for at least 5-6 hours in the cold, 4-8°. If centrifuged 
immediately after pH adjustment, more material precipitated upon sitting. 
The solution was centrifuged at 13,000 x g for 20 minutes. The clear super-
natant solution was then heated in a stainless steel beaker to 65° within 
2-3 minutes and maintained at this temperature for 10 minutes, with stir-
ring. The solution was cooled immediately in an ice bath and centrifuged 
20 minutes at 10,000 x g. The supernatant solution was then brought from 
0 to 33 pe'rcent saturation with respect to (NH4 ) 2S04 (Mann Laboratories) 
using 196 g/liter of solution. After 20-30 minutes of stirring, the solution 
was centrifuged for 20 minutes at 10,000 x g and the supernatant solution 
was brought from 33 to 50 percent (NH4 )2S04 saturation by the addition of 
107 g/liter solution. After 20-60 minutes of stirring, the solution was 
centrifuged 20 minutes at 10,000 x g. The supernatant solution was decanted 
and the precipitate dissolved in a minimum volume of 0.05 M sodium phosphate 
buffer, pH 6.5. The solution was desalted by using a Sephadex G-25 column. 
The column was eluted with 0.05 M phosphate buffer, pH 6.5, and 10 ml frac-
tions were collected until a noticeable turbidity was observed when one 
drop of effluent was added to 1-2 ml of 1 percent BaC12 solution. The pro-
tein was chromatographed on an Amberlite CG-50, Type I column at pH 6.5 and 
0.05 M with respect to sodium phosphate buffer. A linear gradient elution 
was used with 500 ml of 0.05 M sodium phosphate buffer, pH 6.5, and 500 ml 
of 1.0 M NaCl in 0.05 M phosphate buffer, pH 6.5. Five ml fractions were 
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collected at room temperature by an automatic fraction collector (Instrumen-
tation Specialties Co., Inc. , Lincoln ., Nebr, ) . Material not retained on 
the Amberlite column was further chromatographed on a DEAE-cellulose column 
at 0.005 M sodium phosphate buffer, pH 6.5. The column was eluted with a 
linear gradient from 0. 005 M to 1. 0 M sodium phosphate buffer, pH 6. 5, using 
250 ml of each. The column was then eluted wi t h 50 ml of O.lN NaOH. Protein 
content, toxicity, pathological damage and hemagglutinating activity were 
determined on protein fractions obtained from each step. 
E. Evaluation of Toxicity 
Male, albino rats of the Sprague-Dawley strain (Holtzman Co.) ranging 
from 75 to 180 g, were used as tes t animals. The rats were injected 
either intramuscularly in the right hind leg, or intraperitoneally with 
varying levels of the protein fractions. Neither an LD5 o value nor a 
minimum lethal dose was established. Doses were based on µg/100 g body 
weight of the rat (11 ). 
F. Pathological Examination 
Gross observations were made of pathological changes . Selected 
tissue and bone marrow were prepared and obs erved for micros copic find-
ings by the Veterinary Pathol ogy Department J using accepted methods. 
G. Starch Gel Electropµore s is 
The method of Smithies (56 ) was us ed for horizontal s tarch gel elec-
trophoresis. A 13 percent prepa ration of starch (Connaugb.t Medical Research 
Laboratories , Toronto, Canada) was most suitable. The mobility of various 
protein fractions was studied at pH 5. 0 using 0.03 M sodium phosphate 
buffer. Four volts/cm (voltage was checked periodically) were applied 
across the gels for 20-24 hours in a cold room, 4-8°. The gels were 
stained with a saturat ed solution. of Amide Black dye (Eastman Kodak Co.) 
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in methanol, water and acetic aci.d (50:50:10) and decolo,:-ized by a methanol, 
water,acetic acid (50:50:10) solution, 
H. Determination of Hemagglutinating Activity 
A washed suspension of fresh (not over 24 hours) rabbit red blood 
cells in 0.85 percent NaCl solution was used to test the hemagglutinating 
activity of the different ricin fractions. TI-le increase in absorption at 
720 mµ after an incubation period of two hours was measured (11). 
I. Hematocrit and Hemoglobin Studies 
1. H,ematocrits 
Hematocrits were determined for a group of rats (18 for the first 
experiment and 24 for the second) which had been injected with various 
protein fractions at a level of 7.5 µg/100 g body weight. A normal hema-
tocrit value for each animal was established by averaging the values of 
blood samples taken several hours before inJection and Just prior to 
inJection. The blood was obtained by cutting off a small piece of the 
tail with a sharp scapel and then forcing blood o~t rapidly to prevent 
clotting. The samples were collected in heparinized capillary tubes 
(Scientific Products, No. 4hl7 -2) . The samples were then centrifuged in 
a hematocrit centrifuge (International Equipment Co.) for four minutes 
at 11,000 RPM. The ratio of packed red cells to serum was then measured 
using a hematocrit reader · (International Equipment Co.). In the first 
experiment samples were collected every six hours and in the second, 
every four hours except between 11:00 P.M. and 7:00 A.M. Samples were 
collected more frequently Just before the death of the animal. 
2 . Hemoglobin Studies 
Urine samples were collected every 12 hours or until death in 
metabolism cages from rats which had been inJected with 7. 5 µg/100 g body 
weight. Hematest Reagent Tablets (Ames Co., Elkart, Ind) and Hemastix 
Reagent Strips (Ames Co.) were used to test the urine for hemoglobin. 
J. Fumarase Experiments 
Fumarase activity was assayed according to the procedure of Massey (37) 
except that the temperature was not maintained at 20°. Various ricin 
fractions were tested for inhibition. 
K. Effects of Ricin on Mitochondrial Respiration 
Rat liver mitochondria were prepared and their oxygen uptake was 
measured according to procedures given in Umbreit, Burris and Stauffer (68 ). 
Rat liver homogenates were prepared by using 3 ml 0.25 sucrose/g of rat 
liver and then fractionated by differential centrifugation to obtain mito-
chondria. A l:3 dilution of mitochondria in 0. 25 M sucrose was used for 
the experiments. 'nle reaction mixture contained the following 1 : 10 µMoles 
substrate, 500 µg hexokinase (Crude Type, Sigma Chemical Corp.), 3 µMoles 
MgC12 , 150 µMoles nicotine adenine dinucleotide (NAD) (Sigma Chemical Corp.), 
II 3 µMoles ethylenediaminetetraacetic acid tetrasodium salt (EDTA) (Sigma 
Chemical Corp. ) , 10 µMoles potassium phosphate buffer, pH 7. 4, and 0. 1 ml 
ricin solution which had been fractionated through the Amberlite chromato-
graphy step of the old fractionation procedure (11) and represented the 
peak from the first prote in eluted from the column with 0 . 05 M sodium 
phosphate buffer, pH 6 . 5. 'nle center well contained 0 .1 ml 6N KOH absorbed 
on a filter paper wick. 'nle total volume in the flask was 3. 0 ml , which 
included the KOH solution. 'nle following substrates were used: fumarate, 
succinate, a-ketoglutarate and glutamate (California Biochemical Corp.). 
'nle addition of 10 µMoles of pyruvate greatly stimulated the oxidation 
1 Experimental Biochemistry (University of Illinois Laboratory Manual , 
Stipes Publishing Company, Champa in, Illinois, 1959 ) p. 201. 
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rate of fumarate. The substrate plus ricin was tipped into the main 
compartment after five minutes in Experiment A and after ten minutes in 
Experiment B. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Attempts to repeat the fractionation procedure of DasGupta (11) were 
unsuccessful in that a protein fraction which was specific for the liver 
was not found. The elution pattern obtained by DasGupta (11) from an 
Amberlite CG-50, Type I column showed approximately 33.5 percent of the 
protein in peak one which caused marked degenerative changes in the liver 
and 57 percent in peak two which caused marked lymphoid damage. Although 
the same lot of castor seeds was used, the elution pattern differed in 
that: (a) a peak was obtained which corresponded to the reported peak 
one, but it did not show the marked degenerative change in the liver; and 
(b) the remainder of the protein came off continuously in the next 500 
ml collected at concentrations of 0.023 to 0.204 mg/ml (wbich were not 
tested for toxicity). 
A. Fractionation 
1. Comparative Extraction 
Since a number of other investigators had used a 10 percent 
NaCl solution for the extraction of ricin from castor seeds, a brief study 
was made to determine if a higher yield of protein could be obtained than 
when using a 0.85 percent NaCl solution. It was found that only 10-15 
percent more protein was extracted. The higher salt concentration c aused 
peritonitis in rats and consequently was not used in this study. 
2. Heat Treatment 
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Advantage was taken of the heat stability of ricin below 65° 
in developing a new fractionation procedure. According to the study of 
Levy and Benaglia (35) on the effect of pH and heat on crystalline ricin, 
maximum stability to heat was observed to be from pH 4.6 to 5. 1. TI-iere-
fore, the crude ric{n solution was adjusted to pH 5.0 prior to heat treat-
ment. Table I shows the effect of heat treatment on the protein content 
and toxicity of a crude ricin solution which had been adjusted to pH 5.0. 
TABLE I 
EFFECT OF HEAT TREATMENT ON PROTEIN CONCENTRATION A..~D TOXICITY 
Time at 65° C Protein Concentration Toxicity 
(minutes) (mg/ml) (Death in 48 hours) 
Not Heated 11. 0 Not Lethal 
0 6.5 Lethal 
1 6. 1 Lethal 
3 5.6 Lethal 
5 6. 1 Not Lethal 
10 6.4 Lethal 
Five 1 ml aliquots of ricin fractionated through the pH step 
were pipetted into 12 ml heavy duty glass centrifuge tubes . TI-le 
tubes were suspended in a stainless beaker by means of a wire rack . 
TI-le water in the beaker was heated to 65° with stirring. When 
the water had reached 65° (approximately 5-10 minutes) the zero-
time sample was removed and other samples were removed at 1, 3, 5 
and 10 minutes. Each tube was cooled in a beaker filled with ice. 
TI-le solutions were then centrifuged for 10 minutes at 6000 RPM in 
an International clinical centrifuge. Protein was determined as 
described in Experimental Methods. Toxicity was determined by 
injecting a single rat intraperitoneally with 15 µg protein/100 g 
body weight and the animals were observed for 46 hours to deter-
mine time of death. If the animals had not expired, they were 
sacrificed. 
The rat inJected with a ricin solution not heated showed 
symptoms of ricin poisoning which included listlessness, reddening around 
the eyes and nose, and loss of appetite. The animal was sacrificed but no 
degenerative changes were observed. Similar findings were observed for 
the rat inJected with the preparation which had been heated for five min-
utes. The lesions suggested by the action of ricin were very slight in 
this series. Since the soluble proteins were lethal after 10 minutes of 
heating at 65° this step was continually used in fractionating further 
ricin preparations. 
3. Ethanol Treatment 
The effect of ethanol was briefly investigated and the results 
are shown in Table II. 
TABLE II 














st ill living 
3 months later 
To 1 ml of protein solution fractionated through the pH step · 
was added 0 .5 ml of absolute ethanol, which caused the solution 
to become turbid. Addition of another 0 . 5 ml of an ethanol caused 
the formation of a flocculent precipitate. The solution was centri-
fuged for 10 minutes at 6000 RPM in an International clinical 
centrifuge. Protein content was determined as given in Experimental 
Methods. Toxicity was determined by inJecting a single rat with 
15 µg protein/loo g body weight and the rat was observed for 48 
hours. The rat inJected with ricin not treated with ethanol was 
the same as previously discussed (Table I) . 
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The toxicity of the solution was lost upon addition of 
ethanol. Several attempts were made to solubilize the precipitate but 
these were unsuccessful and it was not determined if the precipitate was 
toxic. This approach was not further pursued. 
4. Manganous Chloride Treatment 
The addition of 0.05 percent 1. 0 M MnC12 to a ricin solution 
fractionated through the pH and heat steps showed that some precipitation 
occurred. The resulting supernatant solution retained its toxicity. No 
further investigations were made . 
5. Removal .£! ~ 
The protein fraction obtained from the 33-50 percent satura-
tion with (NI4) 2 S04 was dialyzed against 100 volumes of 0.05 M sodium 
phosphate buffer, pH 6. 5 . It was found that the removal of chloride and 
sulfate ions were not complete after dialyzing for one week. Therefore, 
Sephadex gel was used to desalt the preparation in a shorter time period. 
6. Column Chromatography 
a. Amberlite Chromatography 
Following desalting, the preparation was chromatographed 
on an Amberlite CG- 50, Type I column. The elution pattern is shown in 
Figure 1 . 
b. DEAE-Cellulose Chromatography 
The first peak eluted from the Amberlite column was 
further chromatographed on a DEAE-c.ellulose column . The elution pattern 
is shown in Figure 2, The first peak obtained was toxic at a level of 
5 and 10 µg protein/100 g body we i ght . The other protein eluent was not 
tested. 
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All preparations from both the new and old fractionation 
procedures showed a strong hemagglutinating activity. This confirms and 
extends the previous reports ( 11, 10, J.9) that toxicity and hemagglutina -
ting actiyity are closely associated in protein preparations obtained from 
the seeds of Ricinus communis L. 
6. Starch~ Electrophoresis 
Starch gel electrophoresis was employed to test the homogeneity 
of the various fractions, especially the chromatographed preparations . 
The results are shown in Table IIL 
TABLE III 
STARCH GEL ELECTROPHORETIC MOVEMENT OF RICI N PREPARATIONS 
Ricin Preparation 
Unchromatographed 
(New Fractionation ) 
Amberlite Peak 1 
DEAE-Cellulose 






Movement in cm 
in 23 Hours 
7. 6 
This experiment was performed as given in Experimental Methods. 
The results indicate only one band after Amberlite and DEAE-
cellulose chromatography. 
B. Pathological Observations - Gross and Microscopic 
Table IV shows the gross and microscopic pathological changes of 
rats inJected with the various preparations obtained from the fractiona-
TABLE IV 
PATHOLOGICAL CHANGES IN RATS INJECTED WITH RICIN PREPARATIONS 
INJECTION TIME OF 
PREPARATION SITE DEATH LIVER SPLEEN 
(hours) 
Gross Micro. Gross Micro. 
Crude Ricin 
Solution IP <36 N N N N 
Crude Ricin 1 rat 
Solution IM >48 E N N N 
Unchromatographed 
Ricin Solution IP 24-36 N N N N 
-
Unchromatographed 
Ricin Solution IM 36-48 N N N N 
Amber lite 
Peak l IP <24 N N N N 
Amber lite 
Peak 1 IM 24-36 N Nc-sl N N 
Amber lite 
Peak 2 IP <36 N N Dg-sl N 
Amber lite 
Peak 2 IM 24- 36 N N N Nc-sl 
Level of dose in all cases : 7 . 5 µg protein/ loo g body weight of rat 
Number of rats injected : 3/ preparation 
Abbreviations used: 
Normal = N 
Enlarged• E 
Necrosis = Ne 
Degeneration= Dg 
Degree : Slight • sl 
Moderate=+ 
Marked = ++ 
PATHOLOGICAL CHANGES 
LYMPH EDEMA AT 
NODES INJ. SITE 
Gross Micro. Gross 
N Dg-sl N 
N N + 
R-sl Dg-sl N 
N Dg-sl + 
N Dg-sl N 
N D+ N 
N Dg-sl N 
N Dg+ + 
Intraperitoneally = IP 
Intranruscularly = IM 












Color: Red = R 
Black • B 
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Congestion = C 
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MARR™ 
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tion procedure outlined in this thesis . No marked degenerative changes 
of the liver were observed from any preparat i on ; however, the protein 
(Amberlite peak one , I M inJection) which corresponded to the same frac-
t i on as that previously obtained ( 11 ) , did show a slight necrosis 
(microscopic examination ) in one rat . The similarities in the pathologi-
cal changes of the spleen, lymph node~ mesenter i c lymph nodes and bone 
marrow , and: intestine among all fractions used was striking. Sligh t 
differences which could be related to the i n Jection sit e were observed, 
the noticeable difference being the fluid i n t he serous cavitie s of those 
rats injected i ntraperitoneally. Some evidence for eryth ropoietic stinru -
lation of bone marrow was observed. 
Table V shows pathological changes observed in rats i nJected with 
ricin preparations representing the old ( 11 ) and new fractionation scheme. 
Degenerative changes, varying from slight to marked , occurred in the 
liver, spleen and kidney, and hyperemic , hemorrhagic and necrotic changes 
in the thymus glands from those preparations of the old fractionation 
scheme. The only similarity between ricin preparat i ons of both schemes 
was the change in t h e lymph nodes (Table s N and V. ) . 
In this study t he crude ricin preparations as we l l as t he ch romato-
~ graphed preparations did not show t he extensive degenerative ch anges in 
the liver and the spleen as did the preparat ion s of DasGupta (11 ) . The 
basis for t he difference i s unknown; however , unpublished findings (71 ) 
have shown t h at t he biological activity of r i cin ch ange s markedly on 
aging. The castor seeds in this study were from the same lot grown in 
1958 as those used by DasGupta. However , t h e seeds were 4-5 years of age 
whereas they were 1-2 years of age wh en t he earl i er study was made. 
C. Hematoc r i ts and Hemoglobin Studie s 
TABLE V 
COMPARISON OF PATHOLOGICAL CHANGES IN RATS INJECTED WTTH RlClN FROM TWO FRACTTONATLONS 
PREPARATION NUMBER OF 
RATS INJECTED 
Crude Ricin Solution 1 
Unehromatographed 
Ricin Solution-k- 1 
Unehromatographed 
Ricin Solution* 1 
Chromatographed 
Ric in Solution 




Amberlite Peak 1 * 
3 
* Old fractionation scheme 
**New fractionation scheme 
Abbreviations used: 
Normal • N 
Enlarged ~ E 
Necrosis ~ Ne 
Degeneration= Dg 
LEVEL OF DOSE INJECTION TIME OF 
µg PROTEIN/100 g SITE DEATH 
BODY WEIGHT (hours) 
1 5 IP <24 
10 IP <24 
10 IM < 24 
I 
' 
1 5 IP < 24 I 
i 
' 
' 7. 5 IP <2:..i ' 
' 
' 
Degree: Slight = sl 
Moderate = + 
Marked = ++ 
Exten s i ve = +++ 
PATHOLOGICAL CHANGES 
MESENTERIC 
LIVER SPLEEN LYMPH NODES KIDNEY THYMUS GLAND 
Gross Micro . Gross Micro. Gross Gross Micro. Gross Micro. 
N N D Ne+,++ R-sl N D-sl R Hyp, Hem, 
Ne 
M Dg E, D Ne++ R-sl++ N Dg R-sl++ Hyp, Hem, 
Ne 
N Dg D, M Ne+++ R-sl N Dg R Hyp, Hem, 
Ne 
N N D, M Dg-sl R-sl N N R-sl Hyp 
N N 
I 
N N R, Dg -sl N N N N 
Intraperitoneally = IP Mo ttled = M Color: 
Intramuscularl y = IM Hyperemic = Hyp 








Red = R 





Figure 3 shows an increase in the packed red cell volume of those 
rats inJected intraperitoneally (IP) with all ricin solutions tested ~ 
Since the crude ricin solution, which was not as toxic at the same dose 
level as other fractions (death was delayed or did not occur with the 
amount inJected), caused as great an increase as more toxic fractions, the 
increase in the hematocrit value may not be related to the toxicity. 
Hematocrit values for rats which did not die ( two with I"M inJections of 
crude ricin solution and one with . IM inJection of Amberlite peak two) 
were found to return to normal after 32 hours and 24 hours , respectively. 
Hemoglobin assays on the serum from the blood samples used to 
determine the hematocrits were positive in those that sh owed a slight red -
dening. This indicated that some hemolysis had occurred. This tendency 
was noticed only in the 6- 16 hour period following inJection and not in 
every animal. It was not clearly established whether this hemolysis was 
due to the action of ricin or if it occurred after the blood sample had 
been taken. Hemoglobin assays on the urine of a group of rats which had 
been inJected in a similar manner were negative . The basis for hemolysis 
has not been established. 
The marked increase in hematocrit values observed only in those 
rats inJected IP suggested that the route of the toxin influenced the 
maintenance of cell volume. The toxin might have produced some change 
in the vascular system causing a f luid leakage to occur since many rats 
inJected IP contained increased fluid quantities in the serous cav ity. 
D. Studies on Mechanism of Action 
1. Effect of Ric in on Mitochondrial Respiration 
The results of ricin on mitochondrial r e spiration is shown 
in Table VI. The results show no inhibitory effect on oxygen uptake by 
...:;;:;...:-· 
~:?~~~ ~ ~;-~~~~~~~~£@~~~.:a~~~~~Zf~::i~:~--::---~:":--~~~..:~~:.;_-_~--'" 
-
_,,•'::"-_---~~----._-_-,~_:-_._-_; ___ :_._---_ : ~ __ ; -:---_-_•-~---~---·<-_~•---~::--'.:..--=~ -----,--;.$.1~,c--.---"'·"-'S""-=,;;....,.,,.__~-·;~- ~-=---~~~.-~?~------~---~- - -.,,-~..,~C--
~~~~~~~~~~~~%,:~€;-:-~~-~~-~-~~t'~~;_:t_:fi..:~-:-~:.-;. ~ - ~ - - ...... ~~.:...-- _....--7!&~ -- --~~ ~~~ ~~- -  ... - ~ .. ~ ~""'~ 
--~----.:..:;;:_--=-- --:._,.--~:---~---~_:,~-~ ~----:·z.-...S%;_~-_...,.~~.:. <~'"':,fr;&<,°?.~_F"""':.::.::;_-_;;_~- -- _-_:·--
-- ~-:--:::,;:_------_-_;--~---~- ?_'Z_;__..,;;; J:fu•'o<C?..=-~;;,--· --- -~~"7--,£._fej-j~~_p=-f----- _,---- <-,-- -~c,,-,;,a.=--
-- -~::3.~~:~-~:--~:;·~~~- ci~~-fill.W~~~~~ffe..1,.%i_5:->...::.~ -=-;:'~-----~~- -_:---~ 
------------------



























-141-Fumar ate, Pyruvate 
Fumarate, Pyruvate*~ 58.7 























* The temperature for Experiment A was 30° . 
The temperature for Experiment B was 37°. 
**10 µMoles of each were added 
Total Oxygen 
Uptake in 


















The experiment was performed as given in Experimental Methods. 
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ricin on any of the substrates tested. However, in certain experiments 
there was an increase in respiration in the presence of ricin . 
2. Effect of Ricin £!!_ Crystalline Fumarase 
The effect of ricin on the rate of crystalline fumarase is 
given in Table vrt . 
TABLE VII 
EFFECT OF RICIN ON THE RATE OF CRYSTALLINE FUMARASE 
Addition Protein µg Enzyme Units 
None 10 
0.85% NaCl 10 
Crude Ric in Solution 42. 24 9. 5 
Unchromatographed Ric in 85 10 
Amber lite Peak 2 44.2 10 
Amberlite Peak 1, After 
5 Min. Incubation Period 56 9 
Sodium fumarate (17 µMoles) was used except in the blank 
which contained the same components as the reaction .cuvette. The 
total volume of each cuvette was 3.0 ml. The unit of activity 
was defined as the amount of enzyme which caused an initial rate 
of change of absorbancy at 300 mµ of 0 . 01/minute at room tempera-
ture and pH 7.3 . 
Since many of the ricin solutions tested contained NaCl and fumarase 
activity is sensitive to anions (37) the effect of 0.85 percent NaCl 
solution was tested for any inhibition of rate. No inhibitory affect 
was observed, by either the NaCl solution or by ricin. 
CHAPTER V 
SUMMARY 
Various fractionation procedures were applied to extracts of seeds 
of Ricinus communis L. in an attempt to separate toxic protein frac-
tions for specific organs. While castor seeds of the same lot studied 
two years previously had shown selective toxicity to the liver and 
lymphatic system, none of the preparations of this study showed the 
specific liver damage. 'llle preparations were all toxic and demonstrated 
hemagglutinating activity. 
'llle gross and microscopic pathological changes indicated marked 
degeneration of the lymphatic system and erythropoietic stimulation 
of bone marrow. 'llle route of inJection apparently influenced the path-
ological changes. 
'lllere was no effect of the various preparations on mitochondrial 
respiration or on the activity of crystalline fumarase. 
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